Viewing Study NCT02229227


Ignite Creation Date: 2025-12-25 @ 5:08 AM
Ignite Modification Date: 2025-12-26 @ 4:12 AM
Study NCT ID: NCT02229227
Status: COMPLETED
Last Update Posted: 2020-11-27
First Post: 2014-08-28
Is NOT Gene Therapy: False
Has Adverse Events: True

Brief Title: Safety and Efficacy of Albiglutide + Insulin Glargine Versus Insulin Lispro + Insulin Glargine Subjects With Type 2 Diabetes Mellitus
Sponsor: GlaxoSmithKline
Organization: